Literature DB >> 22791740

Smoking, alcohol consumption, and the risk of amyotrophic lateral sclerosis: a population-based study.

Sonja W de Jong1, Mark H B Huisman, Nadia A Sutedja, Anneke J van der Kooi, Marianne de Visser, Helenius J Schelhaas, Kathelijn Fischer, Jan H Veldink, Leonard H van den Berg.   

Abstract

Smoking has been posited as a possible risk factor for amyotrophic lateral sclerosis (ALS), but large population-based studies of patients with incident disease are still needed. The authors performed a population-based case-control study in the Netherlands between 2006 and 2009, including 494 patients with incident ALS and 1,599 controls. To prove the relevance of population-based incidence cohorts in case-control studies, the authors compared results with those from cohorts including patients with prevalent ALS and referral patients. Subjects were sent a questionnaire. Multivariate analyses showed an increased risk of ALS among current smokers (odds ratio = 1.38, 95% confidence interval (CI): 1.02, 1.88) in the incident patient group only. Cox regression models showed that current smoking was also independently associated with shorter survival (hazard ratio = 1.51, 95% CI: 1.07, 2.15), explaining the lack of association in the prevalent and referral patient groups. Current alcohol consumption was associated with a reduced risk of ALS (incident patient group: odds ratio = 0.52, 95% CI: 0.40, 0.75). These findings indicate that current smoking is associated with an increased risk of ALS, as well as a worse prognosis, and alcohol consumption is associated with a reduced risk of ALS, further corroborating the role of lifestyle factors in the pathogenesis of ALS. The importance of population-based incident patient cohorts in identifying risk factors is highlighted by this study.

Entities:  

Mesh:

Year:  2012        PMID: 22791740     DOI: 10.1093/aje/kws015

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  37 in total

1.  Head injury does not alter disease progression or neuropathologic outcomes in ALS.

Authors:  Christina N Fournier; Marla Gearing; Saila R Upadhyayula; Mitch Klein; Jonathan D Glass
Journal:  Neurology       Date:  2015-04-01       Impact factor: 9.910

Review 2.  The epidemiology of ALS: a conspiracy of genes, environment and time.

Authors:  Ammar Al-Chalabi; Orla Hardiman
Journal:  Nat Rev Neurol       Date:  2013-10-15       Impact factor: 42.937

Review 3.  Association between alcohol consumption and amyotrophic lateral sclerosis: a meta-analysis of five observational studies.

Authors:  Meng E; Sufang Yu; Jianrui Dou; Wu Jin; Xiang Cai; Yiyang Mao; Daojian Zhu; Rumei Yang
Journal:  Neurol Sci       Date:  2016-04-21       Impact factor: 3.307

Review 4.  Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era.

Authors:  Ximena Paez-Colasante; Claudia Figueroa-Romero; Stacey A Sakowski; Stephen A Goutman; Eva L Feldman
Journal:  Nat Rev Neurol       Date:  2015-04-21       Impact factor: 42.937

5.  Heavy Metal Neurotoxicants Induce ALS-Linked TDP-43 Pathology.

Authors:  Peter E A Ash; Uma Dhawan; Samantha Boudeau; Shuwen Lei; Yari Carlomagno; Mark Knobel; Louloua F A Al Mohanna; Steven R Boomhower; M Christopher Newland; David H Sherr; Benjamin Wolozin
Journal:  Toxicol Sci       Date:  2019-01-01       Impact factor: 4.849

Review 6.  Potential Environmental Factors in Amyotrophic Lateral Sclerosis.

Authors:  Björn Oskarsson; D Kevin Horton; Hiroshi Mitsumoto
Journal:  Neurol Clin       Date:  2015-11       Impact factor: 3.806

7.  ALS Multicenter Cohort Study of Oxidative Stress (ALS COSMOS): study methodology, recruitment, and baseline demographic and disease characteristics.

Authors:  Hiroshi Mitsumoto; Pam Factor-Litvak; Howard Andrews; Raymond R Goetz; Leslie Andrews; Judith G Rabkin; Martin McElhiney; Jeri Nieves; Regina M Santella; Jennifer Murphy; Jonathan Hupf; Jess Singleton; David Merle; Mary Kilty; Daragh Heitzman; Richard S Bedlack; Robert G Miller; Jonathan S Katz; Dallas Forshew; Richard J Barohn; Eric J Sorenson; Bjorn Oskarsson; J Americo M Fernandes Filho; Edward J Kasarskis; Catherine Lomen-Hoerth; Tahseen Mozaffar; Yvonne D Rollins; Sharon P Nations; Andrea J Swenson; Jeremy M Shefner; Jinsy A Andrews; Boguslawa A Koczon-Jaremko
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-02-24       Impact factor: 4.092

8.  Population-based study of amyotrophic lateral sclerosis and occupational lead exposure in Denmark.

Authors:  Aisha S Dickerson; Johnni Hansen; Aaron J Specht; Ole Gredal; Marc G Weisskopf
Journal:  Occup Environ Med       Date:  2019-01-31       Impact factor: 4.402

9.  Molgenis-impute: imputation pipeline in a box.

Authors:  Alexandros Kanterakis; Patrick Deelen; Freerk van Dijk; Heorhiy Byelas; Martijn Dijkstra; Morris A Swertz
Journal:  BMC Res Notes       Date:  2015-08-19

10.  Chronic obstructive pulmonary disease is not a risk factor for polyneuropathy: A prospective controlled study.

Authors:  Nora A Visser; Nicolette C Notermans; Ferdinand Teding van Berkhout; Leonard H van den Berg; Alexander Fje Vrancken
Journal:  Chron Respir Dis       Date:  2016-03-15       Impact factor: 2.444

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.